Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 16733
Corporate User License Price USD 750
Corporate User License Price INR 50198
Site License Price USD 500
Site License Price INR 33465
Request a Quote

Report Title

Glaukos Corp (GKOS)-Medical Equipment-Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Glaukos Corp (GKOS)-Medical Equipment-Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Glaukos Corp (GKOS)-Medical Equipment-Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Glaukos Corp (GKOS)-Medical Equipment-Deals and Alliances Profile



Executive Summary

Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. Its products include microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Glaukos' iStent is used in conjunction with cataract surgery. Glauko's iStent improves outflow by creating a patent bypass between the anterior chamber and Schlemm's canal. The company markets its products through a network of distributors in Germany, Italy, Canada, Portugal, Spain, the UK and France. Glaukos is headquartered in San Clemente, California, the US.

Glaukos Corp (GKOS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Glaukos Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Glaukos Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Glaukos Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Glaukos Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Glaukos Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Glaukos Corp, Medical Equipment, Deal Details 11

Asset Purchase 11

Glaukos Acquires IOP Sensor System from DOSE Medical 11

Venture Financing 12

Glaukos Raises US$30 Million In Series F Financing 12

Glaukos Raises US$6 Million In Venture Financing 13

Glaukos Raises US$4.5 Million In Venture Financing 13

GLAUKOS Secures US$29.5 Million In Series E Financing 14

Equity Offering 15

Glaukos Raises USD124.2 Million in IPO 15

Glaukos Corp-Key Competitors 17

Key Employees 18

Locations And Subsidiaries 19

Head Office 19

Other Locations & Subsidiaries 19

Recent Developments 20

Financial Announcements 20

May 03, 2017: Glaukos Announces First Quarter 2017 Financial Results 20

Mar 01, 2017: Glaukos Announces Fourth Quarter & Full Year 2016 Financial Results 21

Nov 10, 2016: Glaukos Announces Third Quarter 2016 Financial Results 22

Aug 01, 2016: Glaukos Announces Second Quarter 2016 Financial Results 23

May 03, 2016: Glaukos Announces First Quarter 2016 Financial Results 24

Mar 01, 2016: Glaukos Announces Fourth Quarter & Full Year 2015 Financial Results 25

Jan 12, 2016: Glaukos Provides Preliminary Fourth Quarter and Full Year 2015 Net Sales and Full Year 2016 Net Sales Guidance 27

Corporate Communications 28

Feb 22, 2017: Preeminent Ophthalmologist, L. Jay Katz Joins Glaukos as Chief Medical Officer 28

Feb 06, 2017: Joseph Gilliam to Join Glaukos Corporation as Chief Financial Officer and Senior Vice President of Corporate Development 29

Feb 01, 2017: Glaukos Promotes Chris M. Calcaterra to Chief Operating Officer 30

Jul 14, 2016: Glaukos Announces Planned Retirement of Chief Financial Officer Richard L. Harrison 31

Apr 14, 2016: Glaukos Announces Retirement Of Olav Bergheim From Board Of Directors 32

Product News 33

May 01, 2017: Several Surgeon Presentations to Include Glaukos Technologies at 2017 American Society of Cataract and Refractive Surgery 33

Feb 08, 2016: Glaukos Establishes Direct Sales Organization and Launches iStent inject Trabecular Micro-Bypass Stent in Australia 37

Feb 01, 2016: Glaukos Launches New Direct Sales Organization and Begins Commercialization of iStent inject Trabecular Micro-Bypass Stent in Canada 38

Jan 20, 2016: International Study Shows 3-Year Benefits of Glaukos iStent Trabecular Micro-Bypass Stent in Combination with Cataract Surgery 39

Jan 07, 2016: Glaukos Will Begin Phase II Clinical Trial For Idose Travoprost Intraocular Implant In Glaucoma Patients 40

Clinical Trials 41

Jan 07, 2016: Glaukos Will Begin Phase II Clinical Trial For Idose Travoprost Intraocular Implant In Glaucoma Patients 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Glaukos Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Glaukos Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Glaukos Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Glaukos Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Glaukos Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Glaukos Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Glaukos Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Glaukos Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Glaukos Corp, Medical Equipment, Key Facts, 2016 1

Glaukos Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Glaukos Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Glaukos Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Glaukos Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Glaukos Corp, Deals By Market, 2011 to YTD 2017 9

Glaukos Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Glaukos Acquires IOP Sensor System from DOSE Medical 11

Glaukos Raises US$30 Million In Series F Financing 12

Glaukos Raises US$6 Million In Venture Financing 13

Glaukos Raises US$4.5 Million In Venture Financing 13

GLAUKOS Secures US$29.5 Million In Series E Financing 14

Glaukos Raises USD124.2 Million in IPO 15

Glaukos Corp, Key Competitors 17

Glaukos Corp, Key Employees 18

Glaukos Corp, Subsidiaries 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Glaukos Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand